|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
WHO004819667 |
| 003 |
DE-627 |
| 005 |
20230425165548.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
210507s2014 xx |||||o 00| ||dan c |
| 035 |
|
|
|a (DE-627)WHO004819667
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)EUCTR2006-003619-29-DK
|
| 035 |
|
|
|a (UBBS_Klinische_Studien_WHO)2005-050
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a dan
|
| 245 |
1 |
0 |
|a Vaccination med peptider deriveret fra anti-apoptotiske proteiner i Bcl-2 familien, administreret i kombination med adjuvant (Montanide ISA-51) i relation til proteasomhæmmerbehandling af patienter med relaps af myelomatose.En fase I/ II undersøgelse
|b Vaccination med peptider deriveret fra anti-apoptotiske proteiner i Bcl-2 familien, administreret i kombination med adjuvant (Montanide ISA-51) i relation til proteasomhæmmerbehandling af patienter med relaps af myelomatose.En fase I/ II undersøgelse
|
| 264 |
|
1 |
|c 2014
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a Computermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-01-2007, Last updated: 2022-11-24
|
| 650 |
|
4 |
|a Medical Condition: Myelomatose med andet eller senere relaps af sygdommen. MedDRA version: 8.1Level: LLTClassification code 10028228Term: Multiple myeloma
|
| 650 |
|
4 |
|a Study Type: Interventional
|
| 650 |
|
4 |
|a Recruitment Status: Not yet recruiting
|
| 650 |
|
4 |
|a 610
|
| 773 |
0 |
8 |
|i Enthalten in
|t WHO International Clinical Trials Registry Platform
|g (2014) vom: 24. Feb.
|
| 773 |
1 |
8 |
|g year:2014
|g day:24
|g month:02
|
| 856 |
4 |
0 |
|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2006-003619-29
|z kostenfrei
|3 Volltext
|
| 912 |
|
|
|a GBV_CTG
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|j 2014
|b 24
|c 02
|
Klinische Studie